Fluidinova produces high quality hydroxyapatite nanoparticles (CAS n. 1306-06-5) as a raw-material for medical devices applications. The
nanoXIM•HAp products present high purity, single-phase, nanocrystalline features and are in compliance with the ISO13779 and ASTM F1185 standards requests for medical applications regarding heavy metals and other specifications.
High Resolution Transmission Electronic Microscopy (HRTEM) analysis reveals that
nanoXIM•HAp products are highly nanocrystalline, presenting the nanocrystals in a structure perfectly aligned.
Other main characteristics of the
nanoXIM•HAp material are the high specific surface BET area (> 100 m
2/g) and the precise stoichiometry of Calcium/Phosphate ions resulting in a Ca/P ratio always near to 1.67. The high consistency level of these materials results in a strongly feasible product for medical applications.
ReferencesProduct Range
nanoXIM•HAp nanocrystalline hydroxyapatite is distributed in the form of water based
pastes with solids content of 15% and 30% and
spray-dried powders.
